ProteinSimple Ella For Complex Multiplex Biomarker Analysis
Platforms

ProteinSimple Ella

For Complex Multiplex Biomarker Analysis

BioAgilytix offers Ella™, from ProteinSimple®, a Bio-Techne® brand, as part of our extensive technology suite supporting complex biomarker work. Our scientists typically turn to Ella for multiplex biomarker analysis in cases where assay variability and antibody cross-reactivity are of particular concern. This platform standardizes sample preparation to ensure each assay is consistently and reproducibly run.

Learn More About Ella:

Still have questions?

BioAgilytix’s experts are here to help. Let’s schedule a conversation to review your questions and requirements with one of our scientists.

proteinsimple ella platform analytical device

How Ella Works

The Ella platform conducts immunoassay testing within a microfluidic Simple Plex™ cartridge. It automates the immunoassay by running samples in parallel through individual microfluidic channels, binding the protein of interest before washing off unbound analyte and adding a detection reagent. Each channel has three Glass Nano Reactors (GNRs) that are coated with a capture antibody so that results are produced in triplicate for each sample.

Ella uses fluorescence detection to enable measurement of low endogenous levels of proteins across a wider and more sensitive detection range. It also precisely controls volume on every assay, resulting in low, single-digit coefficients of variation (CVs).

platform comparison guide

bioagilytix platform comparison guide

What Platform is Best for Your Project?

Use our Platform Comparison Guide to evaluate the optimal method and technology for your assay, based on its unique characteristics and performance requirements.

Download Now

Ideal Ella Applications: Multiplex Biomarker Analysis

BioAgilytix uses the Ella platform for biomarker studies involving multiplex analysis, especially those where assay variability and antibody cross-reactivity could otherwise pose issues. Because it detects each analyte in separate parallel channels, our scientists are able to uphold excellent assay reproducibility with minimal concern for inaccuracy of results due to antibody cross-reactivity.

Ella also yields quantitative data with a 4-5 log dynamic range using as little as 2.5 µL of sample volume. It enables triplicate sample testing with detection of up to four targeted protein antigens. Its use of the Simple Plex™ cartridge makes Ella a viable alternative to traditional plate-based ELISAs for rapid multiplex analysis of small sample volumes.

Key Ella Benefits: High Sensitivity, Reproducible Results, and Low Sample Volume

The Ella platform is able to deliver highly sensitive, reproducible results with low sample volumes. By automating assay runs, it eliminates manual steps for washes and reagent additions, as well as the chance of pipetting errors. This reduces assay variability while speeding analysis time.

Ella’s high sensitivity also makes it valuable for immunoassay studies where limited sample volume is available. Each Simple Plex™ assay yields three results from each microfluidic channel’s three GNRs, helping to maximize each aliquot of sample.

proteinsimple ella platform analysis report

Top Benefits of Ella:

  • Automation
  • High Sensitivity
  • Multiplexing
  • Reduced Cross-Reactivity
  • Reproducible Results
  • Low Sample Volume
biomarkers validate vs. qualify

Biomarker Insight

Exploratory Biomarker Testing: to Qualify or Validate the Assay?

BioAgilytix’s Global CSO, Afshin Safavi, discusses parameters that can help guide decisions on whether to qualify or validate exploratory biomarker assays.

Read More

BioAgilytix’s Ella Platform Expertise

Ella is part of BioAgilytix’s extensive portfolio of bioanalytical technologies and automation systems supporting our core immunoassay services. As a world-class provider of biomarker services, we often deal with complex assay demands, and the Ella platform prepares us to address our customers’ multiplex biomarker analysis challenges effectively.

We are continuously optimizing our support for biomarker studies, and Ella equips us with an advanced tool to quickly and effectively deliver the quality results our customers require.

proteinsimple ella platform benefits

Speak to a Scientist

What would you like to discuss?

With whom will we be speaking?







Sign up for the quarterly newsletter?


biomarker services

Services

See how our premier bioanalytical services support all phases of biomarker, immunogenicity, PK, and cell-based assay studies.

Explore our services

case studies

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Read our case studies